Atorvastatin Calcium
Product Images NDC 68071-2953

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2953). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2953 9)

Atorvastatin Calcium 20 mg tablets, packaged in a container of 90 tablets, labeler NuCare Pharmaceuticals, Inc. The label includes dosage instructions to take the tablets a certain number of times daily, and storage conditions specifying controlled temperature between 68-77°F. It also contains various manufacturing and regulatory details including product and serial numbers, NDC codes, and a warning to keep out of reach of children.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 01)

Chemical structure of atorvastatin calcium depicted with molecular bonds, functional groups, and atomic symbols, including calcium ions and water molecules. The illustration shows the detailed atomic connectivity of the active ingredient atorvastatin calcium.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 02)

A line graph showing cumulative incidence (%) on the y-axis over time in years on the x-axis. It compares the cumulative incidence between atorvastatin and placebo groups, with atorvastatin represented by a solid line and placebo by a dashed line. The graph includes a hazard ratio (HR) of 0.64 with confidence intervals and a p-value.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 03)

A line graph comparing the cumulative hazard percentage over time in years between atorvastatin and placebo groups. The x-axis represents years of follow-up up to 5 years, showing time to first primary endpoint. The y-axis shows cumulative hazard percentage up to 15%. The graph shows lower cumulative hazard with atorvastatin compared to placebo.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 04)

A line graph showing time to first major cardiovascular endpoint over five years comparing atorvastatin 10 mg and atorvastatin 80 mg. The y-axis represents the percentage of subjects experiencing the event, with two lines indicating different dosages. A hazard ratio (HR) and p-value are noted below the graph.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.